| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |